Cadila Healthcare has informed about submission of a copy of press release dated July 24, 2019 titled ‘Zydus has launched Ramelteon Tablets in the US upon receiving final approval from the USFDA’. The contents of the press release give full details.
The above information is a part of company’s filings submitted to BSE.
Trending Stocks
Recommended Articles